Latest total current liabilities for ORPH: $1.8M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2024), ORPH shows a total current liabilities of $1.8M. That compares with $7.3M in the prior-year period — down 75.9% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ORPH's total current liabilities is now $1.8M (was $7.3M) — a 75.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orphazyme A/S is outperforming or lagging.
Tracking ORPH's total current liabilities over time shows whether Orphazyme A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $1.8M That compares with $7.3M in the prior-year period — down 75.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total current liabilities page, Stockcircle has Orphazyme A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $1.8M) with ownership activity and broader fundamentals.
Orphazyme A/S's total current liabilities is $1.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.